Paul Kleutz from the US FDA discusses the issues surrounding the use of patient-reported outcomes in regulatory decision making.
https://ift.tt/2Hy4Lv6
Cancer Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου